Innate Pharma
在场
高管
查看带有其 20 名主要高管的组织结构图
Innate Pharma 搜索最多的简介
- Jonathan Dickinson, Chief Executive Officer and Chairman of the Bo...
- Irina Staatz-Granzer, Chairman of the Board
- Gilles Brisson, Member of the Supervisory Board
高管在Innate Pharma变化
- Jonathan DickinsonJonathan Dickinson 将于202411月1作为 Chief Executive Officer and Chairman of the Board 加入公司 (新闻发布的2024十月14号).
- Herve Brailly 曾任 Interim Chief Executive Officer, 现任 Advisor (新闻发布的2024十月14号).
创建提醒
跟踪 Innate Pharma 的高管变动
药店
Innate Pharma 拥有 1,842 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
- GlycoMimetics and Crescent Biopharma have announced they will merge (公布2024十一月15号)..
- Grace Therapeutics将在Oct 25, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
药店 行业的其他推荐联系人
消息
Innate Pharma 的最新新闻稿
- Innate Pharma reports Third Quarter 2024 Business Update and Financial Results | Innate Pharma
- Innate Pharma announces conference call and webcast for third quarter 2024 results and business updates | Innate Pharma
- Innate Pharma highlights data from its innovative oncology portfolio selected for the SITC Annual Meeting 2024 | Innate Pharma
- Innate Pharma announces its participation in upcoming investor conferences | Innate Pharma
- Innate Pharma appoints Jonathan Dickinson as new Chief Executive Officer and Chairman of the Executive Board | Innate Pharma
- Innate Pharma to host KOL scientific symposium on immunotherapy in New York on October 3, 2024 | Innate Pharma
- Innate Pharma announces FDA clearance of the IND for IPH4502, a Nectin-4 ADC to be developed in solid tumors | Innate Pharma
- Innate Pharma reports First Half 2024 Business Update and Financial Results | Innate Pharma
- All press releases | Innate Pharma
- Monalizumab data from NeoCOAST-2 Phase 2 study in early-stage NSCLC presented at the WCLC 2024 | Innate Pharma
- View more press releases Close
通过电子邮件
